» Articles » PMID: 28835494

ZIC2 Is Essential for Maintenance of Latency and Is a Target of an Immediate Early Protein During Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation

Overview
Journal J Virol
Date 2017 Aug 25
PMID 28835494
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Bivalent histone modifications are defined as repressive and activating epigenetic marks that simultaneously decorate the same genomic region. The H3K27me3 mark silences gene expression, while the H3K4me3 mark prevents the region from becoming permanently silenced and prepares the domain for activation when needed. Specific regions of Kaposi's sarcoma-associated herpesvirus (KSHV) latent episomes are poised to be activated by the KSHV replication and transcription activator (K-Rta). How KSHV episomes are prepared such that they maintain latent infection and switch to lytic replication by K-Rta remains unclear. K-Rta transactivation activity requires a protein degradation function; thus, we hypothesized that identification of cellular substrates of K-Rta may provide insight into the maintenance of KSHV latent infection and the switch to lytic replication. Here we show that a zinc finger protein, ZIC2, a key regulator for central nervous system development, is a substrate of K-Rta and is responsible for maintaining latency. K-Rta directly interacted with ZIC2 and functioned as an E3 ligase to ubiquitinate ZIC2. ZIC2 localized at immediate early and early gene cluster regions of the KSHV genome and contributed to tethering of polycomb repressive complex 2 through physical interaction, thus maintaining H3K27me3 marks at the K-Rta promoter. Accordingly, depletion of ZIC2 shifted the balance of bivalent histone modifications toward more active forms and induced KSHV reactivation in naturally infected cells. We suggest that ZIC2 turnover by K-Rta is a strategy employed by KSHV to favor the transition from latency to lytic replication. Posttranslational histone modifications regulate the accessibility of transcriptional factors to DNA; thus, they have profound effects on gene expression (e.g., viral reactivation). KSHV episomes are known to possess bivalent chromatin domains. How such KSHV chromatin domains are maintained to be reactivatable by K-Rta remains unclear. We found that ZIC2, a transcriptional factor essential for stem cell pluripotency, plays a role in maintaining KSHV latent infection in naturally infected cells. We found that ZIC2 degradation by K-Rta shifts bivalent histone marks to a more active configuration, leading to KSHV reactivation. ZIC2 interacts with and maintains polycomb repressor complex 2 at the K-Rta promoter. Our findings uncover (i) a mechanism utilized by KSHV to maintain latent infection, (ii) a latency-lytic cycle switch operated by K-Rta, and (iii) a molecular mechanism of ZIC2-mediated local histone modification.

Citing Articles

Epigenetic and epitranscriptomic regulation during oncogenic -herpesvirus infection.

Singh R, Vangala R, Torne A, Bose D, Robertson E Front Microbiol. 2025; 15:1484455.

PMID: 39839102 PMC: 11747046. DOI: 10.3389/fmicb.2024.1484455.


KSHV RTA Induces Degradation of the Host Transcription Repressor ID2 To Promote the Viral Lytic Cycle.

Combs L, Spires L, Alonso J, Papp B, Toth Z J Virol. 2022; 96(12):e0010122.

PMID: 35604218 PMC: 9215225. DOI: 10.1128/jvi.00101-22.


Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src/FAK signaling.

Liu A, Xie H, Li R, Ren L, Yang B, Dai L Mol Ther Oncolytics. 2021; 22:195-208.

PMID: 34514099 PMC: 8424131. DOI: 10.1016/j.omto.2021.05.008.


Regulation of KSHV Latency and Lytic Reactivation.

Broussard G, Damania B Viruses. 2020; 12(9).

PMID: 32957532 PMC: 7551196. DOI: 10.3390/v12091034.


Role of Marek's Disease Virus (MDV)-Encoded U3 Serine/Threonine Protein Kinase in Regulating MDV Meq and Cellular CREB Phosphorylation.

Liao Y, Lupiani B, Bajwa K, Khan O, Izumiya Y, Reddy S J Virol. 2020; 94(17).

PMID: 32581093 PMC: 7431815. DOI: 10.1128/JVI.00892-20.


References
1.
Wakeham K, Johnston W, Nalwoga A, Webb E, Mayanja B, Miley W . Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: a nested case-control study. Int J Cancer. 2014; 136(12):2822-30. PMC: 4529666. DOI: 10.1002/ijc.29329. View

2.
Lu D, Searles M, Klug A . Crystal structure of a zinc-finger-RNA complex reveals two modes of molecular recognition. Nature. 2003; 426(6962):96-100. DOI: 10.1038/nature02088. View

3.
Rowe H, Friedli M, Offner S, Verp S, Mesnard D, Marquis J . De novo DNA methylation of endogenous retroviruses is shaped by KRAB-ZFPs/KAP1 and ESET. Development. 2013; 140(3):519-29. PMC: 4892343. DOI: 10.1242/dev.087585. View

4.
Wong E, Damania B . Linking KSHV to human cancer. Curr Oncol Rep. 2005; 7(5):349-56. DOI: 10.1007/s11912-005-0061-6. View

5.
Gould F, Harrison S, Hewitt E, Whitehouse A . Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway. J Virol. 2009; 83(13):6727-38. PMC: 2698570. DOI: 10.1128/JVI.00351-09. View